Cover
Cover | 3 Months Ended |
Mar. 31, 2021 | |
Cover [Abstract] | |
Document Type | S-4 |
Amendment Flag | false |
Entity Registrant Name | Aurora Acquisition Corp. |
Entity Central Index Key | 0001835856 |
Entity Filer Category EntityFilerCategory | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
CONDENSED BALANCE SHEET
CONDENSED BALANCE SHEET - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 | |
Current assets: | |||
Cash | $ 1,999,935 | ||
Prepaid expenses and other current assets | 1,250 | $ 5,000 | |
Total Current Assets | 2,001,185 | 5,000 | |
Cash held in Trust Account | 278,002,870 | ||
Deferred offering cost | 557,663 | ||
Total Assets | 280,004,055 | 562,663 | |
Current liabilities: | |||
Accrued offering costs | 449,841 | 531,947 | |
Promissory note with related party loans | 212,295 | 25,716 | |
Accrued expenses | 13,952 | ||
Total Current Liabilities | 676,088 | 557,663 | |
Warrant liability | 16,753,883 | ||
Deferred underwriting fee payable | 8,505,100 | ||
Total Liabilities | 25,935,071 | 557,663 | |
Commitments and Contingencies | |||
Shareholder's Equity | |||
Additional paid-in capital | 28,236,868 | 24,280 | |
Accumulated deficit | (2,254,911) | (20,000) | |
Total Shareholder's Equity | 25,983,027 | 5,000 | |
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | |||
Total Liabilities and Shareholder's Equity | 280,004,055 | 562,663 | |
Class A Common Stock Subject to Redemption | |||
Current liabilities: | |||
Class A ordinary shares subject to possible redemption, 24,300,287 shares | 228,085,957 | ||
Class A Common Stock Not Subject to Redemption | |||
Shareholder's Equity | |||
Total Shareholder's Equity | 350 | ||
Common stock | 350 | ||
Class B Common Stock | |||
Shareholder's Equity | |||
Total Shareholder's Equity | 720 | 720 | |
Common stock | $ 720 | $ 720 | [1] |
[1] | Includes an aggregate of up to 825,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently issued a cancellation for 131,250 Class B ordinary shares resulting in an aggregate of 6,625,000 founder shares being issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding. All share and per share amounts have been retroactively restated to reflect the share transactions (see Notes 5 and 8). |
CONDENSED BALANCE SHEET (Parent
CONDENSED BALANCE SHEET (Parenthetical) - $ / shares | Mar. 31, 2021 | Feb. 28, 2021 | Dec. 31, 2020 | Oct. 31, 2020 |
Preferred stock, par value | $ 0.0001 | $ 0.0001 | ||
Preferred stock, shares authorized | 5,000,000 | 5,000,000 | ||
Preferred stock, shares issued | 0 | 0 | ||
Preferred stock, shares outstanding | 0 | 0 | ||
Class A Common Stock Subject to Redemption | ||||
Temporary equity, shares issued | 24,300,287 | |||
Temporary equity, shares outstanding | 24,300,287 | |||
Class A Common Stock Not Subject to Redemption | ||||
Common shares, par value | $ 0.0001 | $ 0.0001 | ||
Common shares, shares authorized | 500,000,000 | 500,000,000 | ||
Common shares, shares issued | 3,500,000 | 0 | ||
Common shares, shares outstanding | 3,500,000 | 0 | ||
Class B Common Stock | ||||
Common shares, par value | $ 0.0001 | $ 0.0001 | ||
Common shares, shares authorized | 50,000,000 | 50,000,000 | ||
Common shares, shares issued | 7,200,000 | 6,625,000 | 7,200,000 | |
Common shares, shares outstanding | 7,200,000 | 6,625,000 | 7,200,000 | |
Shares subject to forfeiture | 249,928 | 825,000 | ||
Common stock subject to redemption | ||||
Common shares, shares outstanding | 24,300,287 | |||
Founder Shares | Class B Common Stock | ||||
Common shares, shares issued | 7,200,000 | |||
Common shares, shares outstanding | 7,200,000 | |||
Common shares, issued and outstanding | 7,200,000 | 6,625,000 | ||
Share dividend | 575,000 | |||
Sponsor | Class B Common Stock | ||||
Number of shares surrender | 131,250 | |||
Sponsor | Founder Shares | Class B Common Stock | ||||
Share dividend | 1,006,250 | |||
Sponsor | Founder Shares | Over-allotment option | Class B Common Stock | ||||
Shares subject to forfeiture | 825,000 | 825,000 | 825,000 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | ||
Mar. 31, 2021 | Dec. 31, 2020 | ||
Formation and operating costs | $ 98,419 | $ 20,000 | |
Loss from operations | (98,419) | ||
Other income: | |||
Change in fair value of warrants | (1,836,968) | ||
Offering costs allocated to warrants liability | (299,524) | ||
Net income (loss) | $ (2,234,911) | $ (20,000) | |
Weighted average shares outstanding, basic and diluted | [1] | 6,375,000 | |
Basic and diluted net loss per share | $ 0 | ||
Class A Common Stock Subject to Redemption | |||
Other income: | |||
Weighted average shares outstanding, basic and diluted | 24,300,287 | ||
Basic and diluted net loss per share | $ 0 | ||
Non-Redeemable Class A and Class B Common Stock | |||
Other income: | |||
Weighted average shares outstanding, basic and diluted | 7,218,327 | ||
Basic and diluted net loss per share | $ (0.31) | ||
[1] | Excludes an aggregate of up to 825,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently issued a cancellation for 131,250 shares resulting in an aggregate of 6,625,000 founder shares being issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding. All shares and Class B ordinary share amounts have been retroactively restated to reflect the share transactions (see Notes 5 and 8). |
CONDENSED STATEMENT OF CHANGES
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) | Total | Private Placement | Class A Common Stock Not Subject to Redemption | Class A Common Stock Not Subject to RedemptionPrivate Placement | Class B Common Stock | Additional Paid-in Capital | Additional Paid-in CapitalPrivate Placement | Accumulated Deficit | As Previously Reported | As Previously ReportedClass B Common Stock | As Previously ReportedAdditional Paid-in Capital | As Previously ReportedAccumulated Deficit | |
Beginning balance at Oct. 06, 2020 | $ 0 | $ 0 | $ 0 | $ 0 | |||||||||
Beginning balance, Shares at Oct. 06, 2020 | 0 | ||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||
Issuance of Class B ordinary shares to sponsor | [1] | 25,000 | $ 720 | 24,280 | |||||||||
Issuance of Class B ordinary shares to sponsor, Shares | 7,200,000 | ||||||||||||
Net loss | (20,000) | (20,000) | |||||||||||
Ending balance at Dec. 31, 2020 | 5,000 | $ 720 | 24,280 | (20,000) | $ 5,000 | $ 662 | $ 24,338 | $ (20,000) | |||||
Ending Balance, Shares at Dec. 31, 2020 | 7,200,000 | 6,625,000 | |||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||
Stock Dividend of Class B ordinary shares to Sponsor | $ 58 | (58) | |||||||||||
Stock Dividend of Class B ordinary shares to Sponsor (in Shares) | 575,000 | ||||||||||||
Sale of units | $ 214,438,838 | $ 35,000,000 | $ 2,430 | $ 350 | 214,436,408 | $ 34,999,650 | |||||||
Sale of units (in shares) | 24,300,287 | 24,300,287 | 3,500,000 | ||||||||||
Sale of Private Placement Warrants | $ 6,860,057 | 6,860,057 | |||||||||||
Ordinary shares subject to redemption | (228,085,957) | $ (2,430) | (228,083,527) | ||||||||||
Ordinary shares subject to redemption (in shares) | (24,300,287) | ||||||||||||
Net loss | (2,234,911) | (2,234,911) | |||||||||||
Ending balance at Mar. 31, 2021 | $ 25,983,027 | $ 350 | $ 720 | $ 28,236,868 | $ (2,234,911) | ||||||||
Ending Balance, Shares at Mar. 31, 2021 | 3,500,000 | 7,200,000 | |||||||||||
[1] | Includes an aggregate of up to 825,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently being issued a cancellation for 131,250 Class B ordinary shares resulting in an aggregate of 6,625,000 founder shares issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding. All share and per share amounts have been retroactively restated to reflect the share transactions (see Notes 5 and 8). |
CONDENSED STATEMENT OF CHANGE_2
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - shares | Mar. 10, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | Feb. 28, 2021 | Oct. 31, 2020 |
Sale of units (in shares) | 24,300,287 | ||||
Class B Common Stock | |||||
Shares subject to forfeiture | 249,928 | 825,000 | |||
Private Placement | |||||
Sale of Private Placement Warrants (in shares) | 3,500,000 | ||||
Over-allotment option | |||||
Sale of units (in shares) | 2,300,287 | 3,300,000 | 25,300,000 | ||
Sale of Private Placement Warrants (in shares) | 3,300,000 | ||||
Founder Shares | Class B Common Stock | |||||
Common shares, issued and outstanding | 7,200,000 | 6,625,000 | |||
Share dividend | 575,000 | ||||
Sponsor | Class B Common Stock | |||||
Number of shares surrender | 131,250 | ||||
Sponsor | Founder Shares | Class B Common Stock | |||||
Share dividend | 1,006,250 | ||||
Sponsor | Founder Shares | Over-allotment option | Class B Common Stock | |||||
Shares subject to forfeiture | 825,000 | 825,000 | 825,000 |
CONDENSED STATEMENT OF CASH FLO
CONDENSED STATEMENT OF CASH FLOWS - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (2,234,911) | $ (20,000) |
Adjustment to reconcile net loss to net cash used in operating activities: | ||
Payment of formation costs through issuance of Class B ordinary shares | 5,000 | |
Changes in operating assets and liabilities: | ||
Prepaid expenses and other current assets | 3,750 | (5,000) |
Change in fair value of warrant liability | 1,836,968 | |
Offering cost allocated to warrant liability | 299,523 | |
Accrued expenses | 13,952 | |
Net cash used in operating activities | (80,718) | (20,000) |
Cash Flows from Investing Activities | ||
Investment of cash into Trust Account | (278,002,870) | |
Net cash used in investing activities | (278,002,870) | |
Cash Flows from Financing Activities | ||
Proceeds from sale of Units, net of underwriting discounts paid | 238,142,813 | |
Proceeds from sale of Private Placement Units | 35,000,000 | |
Proceeds from sale of Private Placement Warrants | 6,860,057 | |
Proceeds from promissory note - related party | 80,653 | 25,716 |
Payment of offering costs | (5,716) | |
Net cash provided by financing activities | 280,083,523 | 20,000 |
Net Change in Cash | 1,999,935 | |
Cash - End of period | 1,999,935 | |
Non-cash investing and financing activities: | ||
Deferred Offering Costs | 475,557 | 531,947 |
Proceeds from Promissory Note with Related Party for Offering Cost | 105,927 | |
Deferred offering costs paid directly by sponsor in exchange for issuance of Class B ordinary shares | $ 20,000 | |
Class A ordinary share subject to possible redemption | 228,085,957 | |
Initial Classification of Warrant liability | 14,916,913 | |
Deferred underwriting fee payable | $ 8,505,100 |
CONDENSED STATEMENTS OF OPERA_2
CONDENSED STATEMENTS OF OPERATIONS (Parenthetical) - Class B Common Stock - shares | Mar. 31, 2021 | Feb. 28, 2021 | Dec. 31, 2020 | Oct. 31, 2020 |
Shares subject to forfeiture | 249,928 | 825,000 | ||
Founder Shares | ||||
Common shares, issued and outstanding | 7,200,000 | 6,625,000 | ||
Share dividend | 575,000 | |||
Sponsor | ||||
Number of shares surrender | 131,250 | |||
Sponsor | Founder Shares | ||||
Share dividend | 1,006,250 | |||
Sponsor | Founder Shares | Over-allotment option | ||||
Shares subject to forfeiture | 825,000 | 825,000 | 825,000 |
DESCRIPTION OF ORGANIZATION AND
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Aurora Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on October 7, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company, and as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2021, the Company had not commenced any operations. All activity for the period from October 7, 2020 (inception) through March 31, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. Since our initial public offering, our only cost have been identifying a target for our initial Business Combination. We do not expect to generate any operating revenues until after completion of our initial Business Combination. We generate non-operating The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on March 3, 2021. On March 8, 2021, the Company consummated the Initial Public Offering of 22,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $220,000,000 which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,500,000 private placement units (the “Novator Private Placement Units”) at a price of $10.00 per Novator Private Placement Unit in a private placement to the Sponsor, directors, and executive officers of the Company, generating gross proceeds of $35,000,000 . In addition, the Company consummated the sale of 4,266,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Novator Capital Sponsor Ltd., or Novator, an affiliate of Novator Capital Ltd. (the “Sponsor”) and certain of the Company’s directors and executive officers, generating gross proceeds of $6,400,000, which is described in Note 5. Transaction costs amounted to $13,946,641 consisting of $4,860,057 of underwriting fees, $8,505,100 of deferred underwriting fees (see Note 7) and $581,484 of other offering costs. Following the closing of the Initial Public Offering on March 8, 2021, an amount of $255,000,000 ($10.00 per Unit) (see Note 6) from the net proceeds of the sale of the Units in the Initial Public Offering, the sale of the Novator Private Placement Units and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 On March 10, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 2,300,287 Units issued for an aggregate amount of $23,002,870 in gross proceeds ($22,542,813 of net proceeds). In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 306,705 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $460,057. A total of $23,002,870 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $278,002,870 (see Note 10). The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the sale of the Novator Private Placement Units, the sale of the Private Placement Warrants and the partial exercise of the underwriters’ over-allotment option, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination and to pay the deferred portion of the underwriters’ discount associated with the Initial Public Offering and partial exercise of the underwriters’ over-allotment option. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Initial Public Offering, the exercise of the over-allotment option and Novator Private Placement, management has agreed that $10.00 per Unit sold in the Initial Public Offering, including proceeds of the sale of the Private Placement Warrants and Novator Private Placement Units will be held in a Trust Account and invested in U.S. government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares, with the exception of the founder shares and Novator private placement shares, upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” If the Company seeks shareholder approval in connection with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote their Founder Shares (as defined in Note 6), Novator Private Placement Shares and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent. The Sponsor and the Company’s directors and officers have agreed (a) to waive their redemption rights with respect to any Founder Shares, Novator Private Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial The Company will have until 24 months from the closing of the Initial Public Offering (the “Combination Period”) to complete a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares and Novator Private Placement Shares, at a per-share The Sponsor and the Company’s directors and officers have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or the Company’s directors and officers have acquired Public Shares in or after the Initial Public Offering, such Public Shares and Novator Private Placement Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares and Novator Private Placement Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management has evaluated the impact of the COVID-19 Liquidity and Management’s Plan Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statement. The Company has since competed its Initial Public Offering at which time capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since re-evaluated | NOTE 1—ORGANIZATION AND PLAN OF BUSINESS OPERATIONS Aurora Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on October 7, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from October 7, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the proposed initial public offering (“Proposed Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through a Proposed Public Offering of 22,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit (or 3,000,000 Units if the underwriters’ over-allotment option is exercised in full), which is discussed in Note 3, the sale of 3,500,000 private placement units (the “Novator Private Placement Units”) for $35,000,000 to the sponsor, directors and executive officers of the Company and the sale of 4,266,667 warrants (or 4,706,667 warrants if the underwriters’ over-allotment option is exercised on full) (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Novator Capital Sponsor Ltd., or Novator, an affiliate of Novator Capital Ltd. (the “Sponsor”) and certain of the Company’s directors and executive officers, that will close simultaneously with the Proposed Public Offering. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Public Offering, the sale of the Novator Private Placement Units and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Public Offering and Novator Private Placement, management has agreed that $10.00 per Unit sold in the Proposed Public Offering, including proceeds of the sale of the Private Placement Warrants and Novator Private Placement Units will be held in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares, with the exception of the founder shares and Novator private placement shares, upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Proposed Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” If the Company seeks shareholder approval in connection with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor, Directors and Officers have agreed to vote their Founder Shares (as defined in Note 5), Novator Private Placement Shares and any Public Shares purchased in or after the Proposed Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent. The Sponsor, Directors and Officers have agreed (a) to waive their redemption rights with respect to any Founder Shares, Novator Private Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial The Company will have until 24 months from the closing of the Proposed Public Offering (the “Combination Period”) to complete a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares and Novator Private Placement Shares, at a per-share The Sponsor, Director and Officers have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor, Director and Officers have acquired Public Shares in or after the Proposed Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares and Novator Private Placement Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 Going Concern Consideration At December 31, 2020, the Company had no cash and a working capital deficit of $552,663. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address this uncertainty through a Proposed Public Offering as discussed in Note 3. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
RESTATEMENT OF PREVIOUSLY ISSUE
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Changes and Error Corrections [Abstract] | |
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS | NOTE 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS On April 12, 2021, the Staff of the Securities and Exchange Commission together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a Business Combination, which terms are similar to those contained in the warrant agreement, dated as of March 3, 2021, between the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agreement”). As a result of the SEC Statement, the Company reevaluated the accounting treatment of (i) the 6,075,072 redeemable warrants (the “Public Warrants”) that were included in the units issued by the Company in its initial public offering (the “IPO”) and (ii) the 5,448,372 redeemable warrants that were issued to the Company’s sponsor in a private placement that closed concurrently with the closing of the IPO (the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”, which are discussed in Note 4, Note 5 and Note 8). The Company previously accounted for its outstanding Public Warrants and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. As a result of the Staff Statement discussed above, the Company’s management further evaluated the warrants under ASC Subtopic 815-40, Section 815-40-15 Section 815-40-15, Section 815-40-15 fixed-for-fixed Section 815-40-25. As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued balance sheet issued on March 8, 2021. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company complies with the requirements of ASC 340-10-S99-1 The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported assets. The impact of the restatement of the Company’s audited balance sheet as of March 8, 2021 is reflected in the following table: Balance sheet as of March 8, 2021 As Previously Reported Adjustments As Restated Warrant Liability — 13,882,167.00 13,882,167.00 Common Stock Subject to Possible Redemption 220,000,000.00 (13,882,167.00 ) 206,117,833 Additional Paid in Capital 28,432,458.00 272,651.91 28,705,109.91 Accumulated Deficit (40,326.00 ) (272,651.91 ) (312,977.91 ) |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying financial statements are presented in conformity in U.S. dollars with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021. Investments held in trust account At March 31, 2021, substantially all of the assets held in the Trust Account were held in U.S Treasury securities. Deferred offering costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering and were charged to shareholders’ equity upon the completion of the Initial Public Offering. Class A ordinary shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 Income taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net loss per share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares can be reduced for the effect of an aggregate of 249,928 Class B ordinary shares that are subject to forfeiture if the over-allotment option is exercised by the underwriters within the 45 day window (see Note 8). The Company has not considered the effect of the Warrants sold in the Public Offering and private placement to purchase an aggregate of 11,523,444 shares in the calculation of diluted loss per share, since the exercise of the Warrants are contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of net earnings (loss) per share for common shares subject to possible redemption and applies the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net earnings (loss) per common share (in dollars, except per share amounts): Three Months Class A Common Stock subject to possible redemption Numerator: Earnings attributable to Class A Common Stock subject to possible redemption Net earnings attributable to Class A Common Stock subject to possible redemption $ — Denominator: Weighted average Class A Common Stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption 24,300,287 Basic and diluted net earnings per share, Class A Common Stock subject to possible redemption $ 0.00 Non-Redeemable Numerator: Net loss minus net earnings Net loss $ (2,234,911) Less: Net earnings attributable to Class A Common Stock subject to possible redemption — Non-redeemable $ (2,234,911) Denominator: Weighted average Non-Redeemable Basic and diluted weighted average shares outstanding, Non-Redeemable 7,218,327 Basic and diluted net loss per share, Non-Redeemable $ (0.31) Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000 and up to £85,000 by the Financial Services Compensation Scheme per financial institution in the United Kingdom. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Recent issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. | NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Deferred offering costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Proposed Public Offering and that will be charged to shareholder’s equity upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses incurred, will be charged to operations. Income taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net loss per share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 825,000 Class B ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 7). At December 31, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Recently issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 3 Months Ended |
Mar. 31, 2021 | |
Text Block [Abstract] | |
INITIAL PUBLIC OFFERING | NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 24,300,287 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-fourth In connection with the IPO, the Company granted the underwriters a 45-day |
PRIVATE PLACEMENTS
PRIVATE PLACEMENTS | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Equity [Abstract] | ||
PRIVATE PLACEMENTS | NOTE 5. PRIVATE PLACEMENTS Simultaneously with the closing of the Initial Public Offering, the Sponsor, and certain of the Company’s directors and officers purchased an aggregate of 4,266,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $6,400,000 from the Company. The Sponsor and certain of the Company’s directors and officers have agreed to purchase up to an additional 440,000 Private Placement Warrants, for an aggregate purchase price of an additional $660,000, if the over-allotment option is exercised in full in part by the underwriters (see Note 10). On March 10, the Sponsor and certain of the Company’s directors and officers purchased 306,705 Private Placement Warrants for an additional aggregate purchase price of $460,057 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Sponsor and certain of the Company’s directors and officers also purchased 3,500,000 Novator Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $35,000,000. Each Private Placement Unit consists of one Novator Private Placement Share and one-quarter | NOTE 4—PRIVATE PLACEMENTS The Sponsor, and certain Directors and Officers have committed to purchase an aggregate of 4,266,667 Private Placement Warrants (or 4,706,667 Private Placement Warrants if the underwriters’ over-allotment is exercised in full) at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $6,400,000 (or $7,060,000, if the underwriters’ over-allotment option is exercised in full) from the Company in a private placement that will occur simultaneously with the closing of the Proposed Public Offering. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). The proceeds from the sale of the Private Placement Warrants will be added to the net proceeds from the Proposed Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Sponsor, and certain of our directors, and executive officers have agreed to purchase 3,500,000 Novator Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $35,000,000 in a private placement that will occur simultaneously with the closing of the Proposed Public Offering. Each Private Placement Unit will consist of one Novator Private Placement Share and one-quarter |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Related Party Transactions [Abstract] | ||
RELATED PARTY TRANSACTIONS | NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On December 9, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 5,750,000 shares of Class B ordinary shares (the “Founder Shares”). During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently being issued a cancellation for 131,250 Class B ordinary shares, resulting in an aggregate of 6,625,000 founder shares issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding (see Note 10). The Founder Shares include an aggregate of up to 825,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering and Novator Private Placement. All share and per-share The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares (or Novator Private Placement Shares) until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,500,000 private placement units (the “Novator Private Placement Units”) at a price of $10.00 per Novator Private Placement Unit in a private placement to the Sponsor, directors, and executive officers of the Company, generating gross proceeds of $35,000,000. In addition, the Company consummated the sale of 4,266,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Novator Capital Sponsor Ltd., or Novator, an affiliate of Novator Capital Ltd. (the “Sponsor”) and certain of the Company’s directors and executive officers, generating gross proceeds of $6,400,000, which is described in Note 5. Promissory Note from Related Party On December 9, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the initial shareholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to a maximum of $1,500,000 of such Working Capital Loans (including loans made in connection with a business combination, the payment of offering expenses or otherwise) may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Subsequent to March 31, 2021, the Company entered into a new Promissory Note that would replace the Working Capital Loans (See 10 Subsequent Events). | NOTE 5—RELATED PARTY TRANSACTIONS Founder Shares On December 9, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 5,750,000 shares of Class B ordinary shares (the “Founder Shares”). During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently being issued a cancellation for 131,250 Class B ordinary shares, resulting in an aggregate of 6,625,000 founder shares issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding (see Note 8). The Founder Shares include an aggregate of up to 825,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Proposed Public Offering and Novator Private Placement. All share and per-share The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares (or Novator Private Placement Shares) until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Administrative Services Agreement The Company intends to enter into an agreement, commencing on the date of this Proposed Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of up to $10,000 per month for office space, secretarial and administrative services. Promissory Note—Related Party On November 23, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the initial shareholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to a maximum of $1,500,000 of such Working Capital Loans (including loans made in connection with a business combination, the payment of offering expenses or otherwise) may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. |
COMMITMENTS
COMMITMENTS | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | ||
COMMITMENTS | NOTE 7. COMMITMENTS Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 Registration Rights Pursuant to a registration and shareholder rights agreement entered into on March 3, 2021, the sponsor and the Company’s directors and executive officers have rights to require the Company to register any of its securities held by them for resale under the Securities Act. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, the holders of the Founder Shares, Private Placement Warrants, Novator Private Placement Shares, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants, Novator Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement In connection with the IPO, the Company granted the underwriters a 45-day In addition, the underwriters will be entitled to a deferred fee of $0.35 per Unit. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. | NOTE 6—COMMITMENTS Registration Rights Our sponsor, directors and executive officers will have rights to require us to register any of our securities held by them for resale under the Securities Act pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of this offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that we register such securities for sale under the Securities Act. In addition, the holders of the founder shares, private placement warrants, Novator private placement shares, and warrants that may be issued upon conversion of working capital loans (and any shares of Class A common stock issuable upon the exercise of the private placement warrants, Novator private placement warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the founder shares) will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company will grant the underwriters a 45-day The underwriters will be entitled to a cash underwriting discount of $0.20 per Unit, or $4,400,000 in the aggregate (or $5,060,000 if the underwriters’ over-allotment is exercised in full), payable upon the closing of the Proposed Public Offering. In addition, the underwriters will be entitled to a deferred fee of $0.35 per Unit, or $7,700,000 in the aggregate (or $8,855,000 if the underwriters’ over-allotment is exercised in full). The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. |
SHAREHOLDER'S EQUITY
SHAREHOLDER'S EQUITY | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Federal Home Loan Banks [Abstract] | ||
SHAREHOLDER'S EQUITY | NOTE 8. SHAREHOLDERS’ EQUITY Preference Shares — Class A Ordinary Shares — Class B Ordinary Shares — Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law. The Founder Shares will automatically convert into Class A ordinary shares on the day of the closing of an initial Business Combination, or earlier at the option of the holders thereof, at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted as-converted one-for-one. Warrants — The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 30 business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants for Cash When the Price per Class A Ordinary Share Equals or Exceeds $18.00 • in whole and not in part; • at a price of $0.01 per Public Warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the reported last sales price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants for Class A Ordinary Shares When the Price per Class A Ordinary Share Equals or Exceeds $10.00 • in whole and not in part; • at $0.10 per warrant • upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares; • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within the 30-trading • There will be no redemption rights upon the completion of our initial business combination with respect to our warrants. Our initial shareholders, directors and officers have entered into agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, Novator private placement shares and any public shares they may acquire during or after this offering in connection with the completion of our initial business combination. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants and Novator Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Novator Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Novator Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, | NOTE 7—SHAREHOLDER’S EQUITY Preference Shares — Class A Ordinary Shares — Class B Ordinary Shares — Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law. The Founder Shares will automatically convert into Class A ordinary shares on the day of the closing of an initial Business Combination, or earlier at the option of the holders thereof, at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted as-converted one-for-one. Warrants — The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 30 business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants for Cash When the Price per Class A Ordinary Share Equals or Exceeds $18.00 —Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: • in whole and not in part; • at a price of $0.01 per Public Warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the reported last sales price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants for Class A Ordinary Shares When the Price per Class A Ordinary Share Equals or Exceeds $10.00 —Commencing 90 days after the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant • upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares; • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within the 30-trading • There will be no redemption rights upon the completion of our initial business combination with respect to our warrants. Our initial shareholders, directors and officers have entered into agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, Novator private placement shares and any public shares they may acquire during or after this offering in connection with the completion of our initial business combination. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants and Novator Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Private Placement Warrants and the Novator Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Novator Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | NOTE 9. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured non-financial re-measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. At March 31, 2021, investments held in the Trust account were comprised of $278,002,870 in money market funds which are invested primarily in U.S. Treasury Securities. As of March 31, 2021, the Company did not withdraw any interest income from the Trust Account. The Company utilizes a Monte Carlo simulation model to value the Public Warrants and a Modified Black Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liabilities are determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2021. The following table provides the significant unobservable inputs used in the Monte Carlo Simulation to measure the fair value of the Public Warrants: At March 8, 2021 (Initial Measurement) As of March 31, 2021 Stock price 10.02 10.35 Strike price 11.50 11.50 Probability of completing a Business Combination 90.0 % 90.0 % Expected life of the option to convert (in years) 5.5 5.5 Volatility 15 % 15 % Risk-free rate 0.96 % 1.04 % Fair value of warrants 0.86 1.00 The following table provides the significant unobservable inputs used in the Modified Black Scholes model to measure the fair value of the Private Placement Warrants: At March 8, 2021 (Initial Measurement) As of March 31, 2021 Stock price 10.02 10.02 Strike price 11.50 11.50 Probability of completing a Business Combination 90.0 % 90.0 % Dividend yield — % — % Remaining term (in years) 5.5 5.5 Volatility 24.0 % 24.0 % Risk-free rate 0.96 % 1.04 % Fair value of warrants 0.86 1.00 The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Private Placement Public Warrant Liabilities Fair value as of December 31, 2020 $ — $ — $ — Initial measurement at March 8, 2021 9,152,167 44,730,000 13,882,167 Initial measurement of over-allotment warrants 545,935 488,811 1,034,746 Change in valuation inputs or other assumptions 908,707 856,261 1,836,968 Fair value as of March 31, 2021 $ 10,678,809 $ 6,075,072 $ 16,753,881 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Subsequent Events [Abstract] | ||
SUBSEQUENT EVENTS | NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to May 26, 2021, the date that the financial statement was issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement. As disclosed in the Company’s Current Report on Form 8-K 8-K On May 10, 2021, as a result of the underwriters’ election to partially exercise their over-allotment option, a total of 249,928 Founder Shares were irrevocably surrendered for cancellation and nil consideration. On May 11 th As part of this transaction, SB Management Limited (“SoftBank”), a subsidiary of SoftBank Group Corp., will participate by committing to a $1.5 billion private investment in public equity (“PIPE”) upon closing of the transaction. The Company’s sponsor, Novator Capital, will invest $200M through the PIPE, by taking up a portion of SoftBank’s commitment, and also has committed to backstop any redemptions by Aurora shareholders of funds in its trust account, substantially increasing transaction completion certainty. Also participating in the PIPE is current Better investor, Activant Capital. Subject to customary closing conditions, the transaction is expected to close in the fourth quarter of 2021. On May 11 th non-interest On May 10 th | NOTE 8—SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, other than as described below or in these financial statements, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently issued a cancellation for 131,250 Class B ordinary shares resulting in an aggregate of 6,625,000 founder shares being issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding. All per share amounts have been retroactively restated to reflect the share transactions (see Note 5). |
PROPOSED PUBLIC OFFERING
PROPOSED PUBLIC OFFERING | 3 Months Ended |
Dec. 31, 2020 | |
Cash and Cash Equivalents [Abstract] | |
PROPOSED PUBLIC OFFERING | NOTE 3—PROPOSED PUBLIC OFFERING Pursuant to the Proposed Public Offering, the Company will offer for sale up to 22,000,000 Units (or 25,300,000 Units if the underwriters’ over-allotment option is exercised in full) at a purchase price of $10.00 per Unit. Each Unit will consist of one Class A ordinary share and one-quarter |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Basis of presentation | Basis of presentation The accompanying financial statements are presented in conformity in U.S. dollars with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. | Basis of presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. |
Emerging growth company | Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging | Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging |
Use of estimates | Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. | Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and cash equivalents | Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021. | Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. |
Investments held in trust account | Investments held in trust account At March 31, 2021, substantially all of the assets held in the Trust Account were held in U.S Treasury securities. | |
Deferred offering costs | Deferred offering costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering and were charged to shareholders’ equity upon the completion of the Initial Public Offering. | Deferred offering costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Proposed Public Offering and that will be charged to shareholder’s equity upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses incurred, will be charged to operations. |
Class A ordinary shares subject to possible redemption | Class A ordinary shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. | |
Warrant Liability | Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash | |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 | |
Income taxes | Income taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. | Income taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. |
Net loss per share | Net loss per share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares can be reduced for the effect of an aggregate of 249,928 Class B ordinary shares that are subject to forfeiture if the over-allotment option is exercised by the underwriters within the 45 day window (see Note 8). The Company has not considered the effect of the Warrants sold in the Public Offering and private placement to purchase an aggregate of 11,523,444 shares in the calculation of diluted loss per share, since the exercise of the Warrants are contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of net earnings (loss) per share for common shares subject to possible redemption and applies the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net earnings (loss) per common share (in dollars, except per share amounts): Three Months Class A Common Stock subject to possible redemption Numerator: Earnings attributable to Class A Common Stock subject to possible redemption Net earnings attributable to Class A Common Stock subject to possible redemption $ — Denominator: Weighted average Class A Common Stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption 24,300,287 Basic and diluted net earnings per share, Class A Common Stock subject to possible redemption $ 0.00 Non-Redeemable Numerator: Net loss minus net earnings Net loss $ (2,234,911) Less: Net earnings attributable to Class A Common Stock subject to possible redemption — Non-redeemable $ (2,234,911) Denominator: Weighted average Non-Redeemable Basic and diluted weighted average shares outstanding, Non-Redeemable 7,218,327 Basic and diluted net loss per share, Non-Redeemable $ (0.31) | Net loss per share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 825,000 Class B ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 7). At December 31, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. |
Concentration of credit risk | Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000 and up to £85,000 by the Financial Services Compensation Scheme per financial institution in the United Kingdom. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. | Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Recent issued accounting standards | Recent issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. | Recently issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
RESTATEMENT OF PREVIOUSLY ISS_2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Changes and Error Corrections [Abstract] | |
Schedule of impact of the restatement on the audited consolidated balance sheets | The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported assets. The impact of the restatement of the Company’s audited balance sheet as of March 8, 2021 is reflected in the following table: Balance sheet as of March 8, 2021 As Previously Reported Adjustments As Restated Warrant Liability — 13,882,167.00 13,882,167.00 Common Stock Subject to Possible Redemption 220,000,000.00 (13,882,167.00 ) 206,117,833 Additional Paid in Capital 28,432,458.00 272,651.91 28,705,109.91 Accumulated Deficit (40,326.00 ) (272,651.91 ) (312,977.91 ) |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Reconciliation of Net Loss per Common Share | The following table reflects the calculation of basic and diluted net earnings (loss) per common share (in dollars, except per share amounts): Three Months Class A Common Stock subject to possible redemption Numerator: Earnings attributable to Class A Common Stock subject to possible redemption Net earnings attributable to Class A Common Stock subject to possible redemption $ — Denominator: Weighted average Class A Common Stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption 24,300,287 Basic and diluted net earnings per share, Class A Common Stock subject to possible redemption $ 0.00 Non-Redeemable Numerator: Net loss minus net earnings Net loss $ (2,234,911) Less: Net earnings attributable to Class A Common Stock subject to possible redemption — Non-redeemable $ (2,234,911) Denominator: Weighted average Non-Redeemable Basic and diluted weighted average shares outstanding, Non-Redeemable 7,218,327 Basic and diluted net loss per share, Non-Redeemable $ (0.31) |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of quantitative information regarding Level 3 fair value measurements inputs | The following table provides the significant unobservable inputs used in the Monte Carlo Simulation to measure the fair value of the Public Warrants: At March 8, 2021 (Initial Measurement) As of March 31, 2021 Stock price 10.02 10.35 Strike price 11.50 11.50 Probability of completing a Business Combination 90.0 % 90.0 % Expected life of the option to convert (in years) 5.5 5.5 Volatility 15 % 15 % Risk-free rate 0.96 % 1.04 % Fair value of warrants 0.86 1.00 The following table provides the significant unobservable inputs used in the Modified Black Scholes model to measure the fair value of the Private Placement Warrants: At March 8, 2021 (Initial Measurement) As of March 31, 2021 Stock price 10.02 10.02 Strike price 11.50 11.50 Probability of completing a Business Combination 90.0 % 90.0 % Dividend yield — % — % Remaining term (in years) 5.5 5.5 Volatility 24.0 % 24.0 % Risk-free rate 0.96 % 1.04 % Fair value of warrants 0.86 1.00 |
Schedule of change in the fair value of the warrant liabilities | The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Private Placement Public Warrant Liabilities Fair value as of December 31, 2020 $ — $ — $ — Initial measurement at March 8, 2021 9,152,167 44,730,000 13,882,167 Initial measurement of over-allotment warrants 545,935 488,811 1,034,746 Change in valuation inputs or other assumptions 908,707 856,261 1,836,968 Fair value as of March 31, 2021 $ 10,678,809 $ 6,075,072 $ 16,753,881 |
DESCRIPTION OF ORGANIZATION A_2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Detail) | Mar. 10, 2021USD ($)$ / sharesshares | Mar. 08, 2021USD ($)$ / sharesshares | Mar. 31, 2021USD ($)$ / sharesshares | Dec. 31, 2020USD ($)$ / sharesshares |
Subsidiary, Sale of Stock [Line Items] | ||||
Condition for future business combination number of businesses minimum | 1 | 1 | ||
Sale of units (in shares) | shares | 24,300,287 | |||
Proceeds from sale of Private Placement Warrants | $ 6,860,057 | |||
Transaction Costs | 13,946,641 | |||
Underwriting fees | 4,860,057 | |||
Deferred underwriting fee payable | $ 22,542,813 | 8,505,100 | ||
Other offering costs | 581,484 | |||
Cash held outside the Trust Account | 1,999,935 | |||
Payments for investment of cash in Trust Account | $ (278,002,870) | |||
Condition for future business combination use of proceeds percentage | 80.00% | 80.00% | ||
Condition for future business combination threshold Percentage Ownership | 50.00% | 50.00% | ||
Minimum net tangible assets upon consummation of business combination | $ 5,000,001 | |||
Redemption limit percentage without prior consent | 20.00% | 20.00% | ||
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent) | 100.00% | 100.00% | ||
Redemption period upon closure | 10 days | 10 days | ||
Maximum Allowed Dissolution Expenses | $ 100,000 | $ 100,000 | ||
Working capital deficit | $ 552,663 | |||
Private Placement Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of Private Placement Warrants (in shares) | shares | 4,266,667 | |||
Price of warrant | $ / shares | $ 1.50 | |||
Proceeds from sale of Private Placement Warrants | $ 6,400,000 | |||
Initial Public Offering | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of units (in shares) | shares | 2,300,287 | 22,000,000 | 24,300,287 | 22,000,000 |
Proceeds from issuance initial public offering | $ 220,000,000 | |||
Purchase price, per unit | $ / shares | $ 10 | $ 10 | $ 10 | |
Underwriting fees | $ 4,400,000 | $ 4,860,057 | ||
Other offering costs | 581,484 | 581,484 | ||
Payments for investment of cash in Trust Account | $ 255,000,000 | |||
Minimum net tangible assets upon consummation of business combination | $ 5,000,001 | |||
Private Placement | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of Private Placement Warrants (in shares) | shares | 3,500,000 | |||
Investment Of Proceeds In Trust Account | $ 23,002,870 | |||
Aggregate proceeds held in the Trust Account | $ 278,002,870 | |||
Private Placement | Private Placement Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of Private Placement Warrants (in shares) | shares | 4,266,667 | 4,266,667 | ||
Price of warrant | $ / shares | $ 1.50 | $ 1.50 | ||
Proceeds from sale of Private Placement Warrants | $ 6,400,000 | |||
Underwriters Over Allotment [Member] | Private Placement Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of Private Placement Warrants (in shares) | shares | 4,706,667 | |||
Over-allotment option | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of units (in shares) | shares | 2,300,287 | 3,300,000 | 25,300,000 | |
Proceeds from issuance initial public offering | $ 23,002,870 | |||
Purchase price, per unit | $ / shares | $ 10 | $ 10 | ||
Sale of Private Placement Warrants (in shares) | shares | 3,300,000 | |||
Net Proceeds | $ 22,542,813 | |||
Option is exercised | shares | 3,000,000 | |||
Over-allotment option | Private Placement Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Proceeds from issuance initial public offering | $ 35,000,000 | $ 35,000,000 | ||
Purchase price, per unit | $ / shares | $ 10 | |||
Sale of Private Placement Warrants (in shares) | shares | 306,705 | 3,500,000 | 3,500,000 | |
Price of warrant | $ / shares | $ 1.50 | |||
Proceeds from sale of Private Placement Warrants | $ 460,057 |
RESTATEMENT OF PREVIOUSLY ISS_3
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Detail) - USD ($) | Mar. 08, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | Mar. 03, 2021 |
CONDENSED BALANCE SHEET | ||||
Offering costs | $ 5,716 | |||
Underwriting fees | $ 4,860,057 | |||
Other offering costs | 581,484 | |||
Warrant liability | $ 13,882,167 | 16,753,883 | ||
Common Stock Subject to Possible Redemption | 206,117,833 | |||
Additional paid-in capital | 28,705,109.91 | 28,236,868 | 24,280 | |
Accumulated deficit | (312,977.91) | (2,254,911) | $ (20,000) | |
As Previously Reported | ||||
CONDENSED BALANCE SHEET | ||||
Common Stock Subject to Possible Redemption | 220,000,000 | |||
Additional paid-in capital | 28,432,458 | |||
Accumulated deficit | (40,326) | |||
Adjustments | ||||
CONDENSED BALANCE SHEET | ||||
Warrant liability | 13,882,167 | |||
Common Stock Subject to Possible Redemption | (13,882,167) | |||
Additional paid-in capital | 272,651.91 | |||
Accumulated deficit | (272,651.91) | |||
Initial Public Offering | ||||
CONDENSED BALANCE SHEET | ||||
Offering costs | 12,681,484 | 13,946,641 | ||
Underwriting fees | 4,400,000 | 4,860,057 | ||
Deferred underwriting fees | 7,700,000 | 8,505,100 | ||
Other offering costs | 581,484 | 581,484 | ||
Offering costs charged to shareholders' equity | 12,408,832 | 13,647,105 | ||
Initial Public Offering | Public Warrants | ||||
CONDENSED BALANCE SHEET | ||||
Redeemable warrants | 6,075,072 | |||
Offering costs | $ 272,652 | $ 299,523 | ||
Initial Public Offering | Private Placement Warrants | ||||
CONDENSED BALANCE SHEET | ||||
Redeemable warrants | 5,448,372 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail) - USD ($) | Mar. 08, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Summary Of Significant Accounting Policy [Line Items] | |||
Offering costs | $ 5,716 | ||
Underwriting fees | $ 4,860,057 | ||
Other offering costs | 581,484 | ||
Unrecognized tax benefits accrued for interest and penalties | $ 0 | ||
Unrecognized tax benefits | $ 0 | ||
Shares excluded from calculation of diluted loss per share | 11,523,444 | ||
Initial Public Offering | |||
Summary Of Significant Accounting Policy [Line Items] | |||
Offering costs | $ 12,681,484 | $ 13,946,641 | |
Underwriting fees | 4,400,000 | 4,860,057 | |
Deferred underwriting fees | 7,700,000 | 8,505,100 | |
Other offering costs | 581,484 | 581,484 | |
Offering costs charged to shareholders' equity | 12,408,832 | 13,647,105 | |
Initial Public Offering | Public Warrants | |||
Summary Of Significant Accounting Policy [Line Items] | |||
Offering costs | $ 272,652 | $ 299,523 | |
Class B Common Stock | |||
Summary Of Significant Accounting Policy [Line Items] | |||
Shares subject to forfeiture | 249,928 | 825,000 |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Reconciliation of Net Loss per Common Share (Detail) - USD ($) | 3 Months Ended | ||
Mar. 31, 2021 | Dec. 31, 2020 | ||
Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption | [1] | 6,375,000 | |
Basic and diluted net earnings per share, Class A Common Stock subject to possible redemption | $ 0 | ||
Net loss | $ (2,234,911) | $ (20,000) | |
Class A Common Stock Subject to Redemption | |||
Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption | 24,300,287 | ||
Basic and diluted net earnings per share, Class A Common Stock subject to possible redemption | $ 0 | ||
Non-Redeemable Class A and Class B Common Stock | |||
Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption | 7,218,327 | ||
Basic and diluted net earnings per share, Class A Common Stock subject to possible redemption | $ (0.31) | ||
Net loss | $ (2,234,911) | ||
Non-redeemable net loss | $ (2,234,911) | ||
[1] | Excludes an aggregate of up to 825,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. During February 2021, the Company effectuated a share dividend of 1,006,250 Class B ordinary shares and subsequently issued a cancellation for 131,250 shares resulting in an aggregate of 6,625,000 founder shares being issued and outstanding. In March 2021, the Company effectuated a share dividend of 575,000 shares resulting in 7,200,000 founder shares issued and outstanding. All shares and Class B ordinary share amounts have been retroactively restated to reflect the share transactions (see Notes 5 and 8). |
INITIAL PUBLIC OFFERING (Detail
INITIAL PUBLIC OFFERING (Detail) - $ / shares | Mar. 10, 2021 | Mar. 08, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 24,300,287 | |||
Initial Public Offering | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 2,300,287 | 22,000,000 | 24,300,287 | 22,000,000 |
Purchase price, per unit | $ 10 | $ 10 | $ 10 | |
Initial Public Offering | Public Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of shares in a unit | 1 | 1 | ||
Number of warrants in a unit | 0.25 | 0.25 | ||
Number of shares issuable per warrant | 1 | 1 | ||
Exercise price of warrants | $ 11.50 | $ 11.5 | ||
Over-allotment option | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 2,300,287 | 3,300,000 | 25,300,000 | |
Purchase price, per unit | $ 10 | $ 10 |
PRIVATE PLACEMENTS (Detail)
PRIVATE PLACEMENTS (Detail) - USD ($) | Mar. 10, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Subsidiary, Sale of Stock [Line Items] | |||
Aggregate purchase price | $ 6,860,057 | ||
Sponsor and certain of Company's directors and officers | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of shares per warrant | 1 | ||
Exercise price of warrant | $ 11.50 | $ 11.50 | |
Private Placement Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 4,266,667 | ||
Price of warrants | $ 1.50 | ||
Aggregate purchase price | $ 6,400,000 | ||
Private Placement Warrants | Sponsor and certain of Company's directors and officers | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of shares per warrant | 1 | ||
Private Placement Warrants | Sponsor and certain of Company's directors and officers | Common Class A [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Price of warrants | $ 11.50 | ||
Number of shares per warrant | 1 | ||
Exercise price of warrant | $ 11.50 | ||
Novator Private Placement Share | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 3,500,000 | ||
Price of warrants | $ 10 | ||
Aggregate purchase price | $ 35,000,000 | ||
Novator Private Placement Share | Sponsor and certain of Company's directors and officers | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 3,500,000 | 3,500,000 | |
Price of warrants | $ 10 | $ 10 | |
Aggregate purchase price | $ 35,000,000 | $ 35,000,000 | |
Number of shares per warrant | 1 | ||
Private Placement | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 3,500,000 | ||
Private Placement | Private Placement Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 4,266,667 | 4,266,667 | |
Price of warrants | $ 1.50 | $ 1.50 | |
Aggregate purchase price | $ 6,400,000 | ||
Private Placement | Private Placement Warrants | Sponsor and certain of Company's directors and officers | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 4,266,667 | 4,266,667 | |
Price of warrants | $ 1.50 | $ 1.50 | |
Aggregate purchase price | $ 6,400,000 | $ 6,400,000 | |
Over-allotment option | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 3,300,000 | ||
Over-allotment option | Private Placement Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 306,705 | 3,500,000 | 3,500,000 |
Price of warrants | $ 1.50 | ||
Aggregate purchase price | $ 460,057 | ||
Over-allotment option | Private Placement Warrants | Sponsor and certain of Company's directors and officers | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 306,705 | 440,000 | 4,706,667 |
Price of warrants | $ 11.50 | ||
Aggregate purchase price | $ 460,057 | $ 660,000 | $ 7,060,000 |
RELATED PARTY TRANSACTIONS - Fo
RELATED PARTY TRANSACTIONS - Founder Shares (Detail) - Class B Common Stock | Dec. 09, 2020USD ($)d$ / sharesshares | Oct. 31, 2020shares | Mar. 31, 2021shares | Feb. 28, 2021shares | Mar. 31, 2021shares | Dec. 31, 2020shares |
Related Party Transaction [Line Items] | ||||||
Share dividend | 575,000 | |||||
Common shares, shares outstanding | 7,200,000 | 6,625,000 | 7,200,000 | 7,200,000 | ||
Common shares, shares issued | 7,200,000 | 6,625,000 | 7,200,000 | 7,200,000 | ||
Shares subject to forfeiture | 249,928 | 249,928 | 825,000 | |||
SUBSEQUENT EVENTS | ||||||
Related Party Transaction [Line Items] | ||||||
Common shares, shares outstanding | 6,625,000 | |||||
Common shares, shares issued | 6,625,000 | |||||
Sponsor | ||||||
Related Party Transaction [Line Items] | ||||||
Number of shares surrender | 131,250 | |||||
Sponsor | SUBSEQUENT EVENTS | ||||||
Related Party Transaction [Line Items] | ||||||
Number of shares surrender | 131,250 | |||||
Founder Shares | ||||||
Related Party Transaction [Line Items] | ||||||
Share dividend | 575,000 | |||||
Common shares, shares outstanding | 7,200,000 | 7,200,000 | ||||
Common shares, shares issued | 7,200,000 | 7,200,000 | ||||
Founder Shares | SUBSEQUENT EVENTS | ||||||
Related Party Transaction [Line Items] | ||||||
Share dividend | 575,000 | 1,006,250 | ||||
Common shares, shares outstanding | 7,200,000 | 6,625,000 | 7,200,000 | |||
Common shares, shares issued | 7,200,000 | 6,625,000 | 7,200,000 | |||
Founder Shares | Sponsor | ||||||
Related Party Transaction [Line Items] | ||||||
Consideration received | $ | $ 25,000 | |||||
Consideration received, shares | 5,750,000 | |||||
Share dividend | 1,006,250 | |||||
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders | 20.00% | 20.00% | ||||
Restrictions on transfer period of time after business combination completion | 1 year | |||||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 12 | |||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | d | 20 | |||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | d | 30 | |||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | |||||
Founder Shares | Sponsor | Over-allotment option | ||||||
Related Party Transaction [Line Items] | ||||||
Shares subject to forfeiture | 825,000 | 825,000 | 825,000 | 825,000 | ||
Founder Shares | Sponsor | SUBSEQUENT EVENTS | ||||||
Related Party Transaction [Line Items] | ||||||
Share dividend | 1,006,250 |
RELATED PARTY TRANSACTIONS - Ad
RELATED PARTY TRANSACTIONS - Additional Information (Detail) - USD ($) | 3 Months Ended | ||
Mar. 31, 2021 | Dec. 31, 2020 | Dec. 09, 2020 | |
Related Party Transaction [Line Items] | |||
Proceeds from sale of Private Placement Warrants | $ 6,860,057 | ||
Sponsor | |||
Related Party Transaction [Line Items] | |||
Monthly office space rent | $ 10,000 | ||
Novator Private Placement Share | |||
Related Party Transaction [Line Items] | |||
Number of warrants to purchase shares issued | 3,500,000 | ||
Price of warrant | $ 10 | ||
Proceeds from sale of Private Placement Warrants | $ 35,000,000 | ||
Private Placement Warrants | |||
Related Party Transaction [Line Items] | |||
Number of warrants to purchase shares issued | 4,266,667 | ||
Price of warrant | $ 1.50 | ||
Proceeds from sale of Private Placement Warrants | $ 6,400,000 | ||
Promissory Note from Related Party | |||
Related Party Transaction [Line Items] | |||
Maximum borrowing capacity of related party promissory note | $ 300,000 | ||
Repayment of promissory note - related party | 212,295 | 25,716 | |
Related Party Loans | |||
Related Party Transaction [Line Items] | |||
Loan conversion agreement warrant | $ 1,500,000 | $ 1,500,000 | |
Price of warrant | $ 1.50 | ||
Related Party Loans | Working capital loans warrant | |||
Related Party Transaction [Line Items] | |||
Price of warrant | $ 1.50 |
COMMITMENTS (Detail)
COMMITMENTS (Detail) - USD ($) | Mar. 10, 2021 | Mar. 08, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Gain Contingencies [Line Items] | ||||
Number of units sold | 24,300,287 | |||
Deferred fee per unit | $ 0.35 | $ 0.35 | ||
Net proceeds | $ 22,542,813 | $ 8,505,100 | ||
Gross Proceeds | $ 23,002,870 | |||
Underwriting fee (in percentage) | 2.00% | |||
Per unit Underwriting expense | $ 0.20 | |||
Underwriters discount | $ 4,400,000 | |||
Deferred underwriting discount | $ 7,700,000 | |||
Over-allotment option | ||||
Gain Contingencies [Line Items] | ||||
Number of units sold | 2,300,287 | 3,300,000 | 25,300,000 | |
Share Price | $ 10 | |||
Option to purchase units | 3,300,000 | |||
Underwriters discount | $ 5,060,000 | |||
Deferred underwriting discount | $ 8,855,000 | |||
Initial Public Offering | ||||
Gain Contingencies [Line Items] | ||||
Number of units sold | 2,300,287 | 22,000,000 | 24,300,287 | 22,000,000 |
SHAREHOLDERS' EQUITY - Preferre
SHAREHOLDERS' EQUITY - Preferred Stock Shares (Detail) - $ / shares | Mar. 31, 2021 | Dec. 31, 2020 |
Stockholders' Equity Note [Abstract] | ||
Preferred shares, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred shares, shares issued | 0 | 0 |
Preferred shares, shares outstanding | 0 | 0 |
SHAREHOLDERS' EQUITY - Common S
SHAREHOLDERS' EQUITY - Common Stock Shares (Detail) | 3 Months Ended | ||
Mar. 31, 2021Vote$ / sharesshares | Dec. 31, 2020Vote$ / sharesshares | Feb. 28, 2021shares | |
Class A Common Stock Subject to Redemption | |||
Class of Stock [Line Items] | |||
Class A common stock subject to possible redemption, issued (in shares) | 24,300,287 | ||
Class A common stock subject to possible redemption, outstanding (in shares) | 24,300,287 | ||
Class A Common Stock Not Subject to Redemption | |||
Class of Stock [Line Items] | |||
Common shares, shares authorized (in shares) | 500,000,000 | 500,000,000 | |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |
Common shares, votes per share | Vote | 1 | 1 | |
Common shares, shares issued (in shares) | 3,500,000 | 0 | |
Common shares, shares outstanding (in shares) | 3,500,000 | 0 | |
Class B Common Stock | |||
Class of Stock [Line Items] | |||
Common shares, shares authorized (in shares) | 50,000,000 | 50,000,000 | |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |
Common shares, votes per share | Vote | 1 | 1 | |
Common shares, shares issued (in shares) | 7,200,000 | 7,200,000 | 6,625,000 |
Common shares, shares outstanding (in shares) | 7,200,000 | 7,200,000 | 6,625,000 |
Shares subject to forfeiture | 249,928 | 825,000 | |
Ratio to be applied to the stock in the conversion | 20 | 20 |
SHAREHOLDERS' EQUITY - Warrants
SHAREHOLDERS' EQUITY - Warrants (Detail) | 3 Months Ended | |
Mar. 31, 2021Item$ / shares | Dec. 31, 2020Item$ / shares | |
Class B Common Stock | ||
Class of Warrant or Right [Line Items] | ||
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent) | 20.00% | 20.00% |
Warrants | ||
Class of Warrant or Right [Line Items] | ||
Maximum period after business combination in which to file registration statement | 30 days | 30 days |
Public Warrants | ||
Class of Warrant or Right [Line Items] | ||
Warrant exercise period condition one | 30 days | 30 days |
Warrant exercise period condition two | 12 months | 12 months |
Public Warrants expiration term | 5 years | 5 years |
Share price trigger used to measure dilution of warrant | $ 9.20 | $ 9.20 |
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant | 60.00% | 60.00% |
Trading period after business combination used to measure dilution of warrant | Item | 10 | 10 |
Warrant exercise price adjustment multiple | 115.00% | 115.00% |
Warrant redemption price adjustment multiple | 180.00% | 180.00% |
Restrictions on transfer period of time after business combination completion | 30 days | 30 days |
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 | ||
Class of Warrant or Right [Line Items] | ||
Warrant redemption condition minimum share price | $ 18 | $ 18 |
Redemption price per public warrant (in dollars per share) | $ 0.01 | $ 0.01 |
Threshold trading days for redemption of public warrants | 20 days | 20 days |
Threshold consecutive trading days for redemption of public warrants | 30 days | 30 days |
Threshold number of business days before sending notice of redemption to warrant holders | Item | 3 | 3 |
Redemption period | 30 days | 30 days |
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 | ||
Class of Warrant or Right [Line Items] | ||
Warrant redemption condition minimum share price | $ 10 | $ 10 |
Redemption price per public warrant (in dollars per share) | $ 0.10 | $ 0.10 |
Threshold trading days for redemption of public warrants | 20 days | 20 days |
Threshold number of business days before sending notice of redemption to warrant holders | Item | 3 | 3 |
Redemption period | 30 days | 30 days |
FAIR VALUE MEASUREMENTS (Detail
FAIR VALUE MEASUREMENTS (Detail) | 3 Months Ended |
Mar. 31, 2021USD ($) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Cash and marketable securities held in Trust Account | $ 278,002,870 |
Fair value assets level 1 to level 2 transfers | 0 |
Fair value assets level 2 to level 1 transfers | 0 |
Fair value assets transferred into (out of) level 3 | 0 |
U.S. Treasury Securities | Money market funds | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Cash and marketable securities held in Trust Account | $ 278,002,870 |
FAIR VALUE MEASUREMENTS - Level
FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Detail) - Level 3 | Mar. 31, 2021 | Mar. 08, 2021 |
Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 1 | 0.86 |
Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 1 | 0.86 |
Stock price | Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 10.35 | 10.02 |
Stock price | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 10.02 | 10.02 |
Strike price | Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 11.50 | 11.50 |
Strike price | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 11.50 | 11.50 |
Probability of completing a Business Combination | Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 90 | 90 |
Probability of completing a Business Combination | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 90 | 90 |
Dividend rate | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 0 | 0 |
Expected life of the option to convert (in years) | Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 5.5 | 5.5 |
Expected life of the option to convert (in years) | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 5.5 | 5.5 |
Volatility | Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 15 | 15 |
Volatility | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 24 | 24 |
Risk-free rate | Public Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 1.04 | 0.96 |
Risk-free rate | Private Placement Warrants | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 1.04 | 0.96 |
FAIR VALUE MEASUREMENTS - Chang
FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Detail) - Level 3 - Recurring | 3 Months Ended |
Mar. 31, 2021USD ($) | |
Warrants | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Initial measurement | $ 13,882,167 |
Change in valuation inputs or other assumptions | 1,836,968 |
Fair value as of March 31, 2021 | 16,753,881 |
Warrants | Over-allotment option | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Initial measurement | 1,034,746 |
Public Warrants | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Initial measurement | 44,730,000 |
Change in valuation inputs or other assumptions | 856,261 |
Fair value as of March 31, 2021 | 6,075,072 |
Public Warrants | Over-allotment option | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Initial measurement | 488,811 |
Private Placement Warrants | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Initial measurement | 9,152,167 |
Change in valuation inputs or other assumptions | 908,707 |
Fair value as of March 31, 2021 | 10,678,809 |
Private Placement Warrants | Over-allotment option | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Initial measurement | $ 545,935 |
SUBSEQUENT EVENTS (Detail)
SUBSEQUENT EVENTS (Detail) - USD ($) | May 11, 2021 | May 10, 2021 | Mar. 31, 2021 | Feb. 28, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | Dec. 09, 2020 |
Sponsor | Unsecured Promissory Note | |||||||
Subsequent Event [Line Items] | |||||||
Aggregate principal amount | $ 300,000 | ||||||
Class B Common Stock | |||||||
Subsequent Event [Line Items] | |||||||
Share dividend | 575,000 | ||||||
Common shares, shares outstanding | 7,200,000 | 6,625,000 | 7,200,000 | 7,200,000 | |||
Common shares, shares issued | 7,200,000 | 6,625,000 | 7,200,000 | 7,200,000 | |||
Founder Shares | Class B Common Stock | |||||||
Subsequent Event [Line Items] | |||||||
Share dividend | 575,000 | ||||||
Common shares, shares outstanding | 7,200,000 | 7,200,000 | |||||
Common shares, shares issued | 7,200,000 | 7,200,000 | |||||
SUBSEQUENT EVENTS | Over-allotment option | |||||||
Subsequent Event [Line Items] | |||||||
Founder shares surrendered for cancellation | 249,928 | ||||||
Consideration | $ 0 | ||||||
SUBSEQUENT EVENTS | Sponsor | Unsecured Promissory Note | |||||||
Subsequent Event [Line Items] | |||||||
Aggregate principal amount | $ 2,000,000 | ||||||
SUBSEQUENT EVENTS | PIPE | SB Management Limited | |||||||
Subsequent Event [Line Items] | |||||||
Amount of investment | 1,500,000,000 | ||||||
SUBSEQUENT EVENTS | PIPE | Sponsor | |||||||
Subsequent Event [Line Items] | |||||||
Amount of investment | 200,000,000 | ||||||
SUBSEQUENT EVENTS | Definitive Merger Agreement | Better Holdco Inc. | |||||||
Subsequent Event [Line Items] | |||||||
Equity value | 6,900,000,000 | ||||||
Post-money equity value | $ 7,700,000,000 | ||||||
SUBSEQUENT EVENTS | Class B Common Stock | |||||||
Subsequent Event [Line Items] | |||||||
Common shares, shares outstanding | 6,625,000 | ||||||
Common shares, shares issued | 6,625,000 | ||||||
SUBSEQUENT EVENTS | Founder Shares | Class B Common Stock | |||||||
Subsequent Event [Line Items] | |||||||
Share dividend | 575,000 | 1,006,250 | |||||
Common shares, shares outstanding | 7,200,000 | 6,625,000 | 7,200,000 | ||||
Common shares, shares issued | 7,200,000 | 6,625,000 | 7,200,000 | ||||
SUBSEQUENT EVENTS | Sponsor | Class B Common Stock | |||||||
Subsequent Event [Line Items] | |||||||
Number of shares surrender | 131,250 |
PROPOSED PUBLIC OFFERING (Detai
PROPOSED PUBLIC OFFERING (Detail) - $ / shares | Mar. 10, 2021 | Mar. 08, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Subsidiary or Equity Method Investee [Line Items] | ||||
Number of units sold | 24,300,287 | |||
Initial Public Offering | ||||
Subsidiary or Equity Method Investee [Line Items] | ||||
Number of units sold | 2,300,287 | 22,000,000 | 24,300,287 | 22,000,000 |
Purchase price, per unit | $ 10 | $ 10 | $ 10 | |
Initial Public Offering | Public Warrants | ||||
Subsidiary or Equity Method Investee [Line Items] | ||||
Number of shares in a unit | 1 | 1 | ||
Number of warrants in a unit | 0.25 | 0.25 | ||
Number of shares issuable per warrant | 1 | 1 | ||
Exercise price of warrants | $ 11.50 | $ 11.5 | ||
Over-allotment option | ||||
Subsidiary or Equity Method Investee [Line Items] | ||||
Number of units sold | 2,300,287 | 3,300,000 | 25,300,000 | |
Purchase price, per unit | $ 10 | $ 10 |